Key facts
- This page summarizes Joshua Silverman's Form 4 filing for PharmaCyte Biotech, Inc. (PMCB).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 07 Jan 2026, 17:43.
Joshua Silverman - 05 Jan 2026 Form 4 Insider Report for PharmaCyte Biotech, Inc. (PMCB)
- Reporting relationship
- CEO and President, Director
- Issuer ticker
- PMCB
- Reported as of
- 05 Jan 2026
- Net transaction value
- +$80,476
- SEC form
- 4
- Accepted by SEC
- 07 Jan 2026, 17:43:33 UTC
- Prior SEC filing
- 02 Jan 2026
- Next SEC filing
- 18 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joshua N. Silverman
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Joshua Silverman filed Form 4 for PharmaCyte Biotech, Inc. (PMCB) on 07 Jan 2026.
Change
- Previous filing in this sequence was filed on 02 Jan 2026.
- Current net transaction value: +$80,476.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001524858
Primary reporting owner
Silverman Joshua
- Relationship
- CEO and President, Director
- Address
- C/O PHARMACYTE BIOTECH, INC., 3960 HOWARD HUGHES PARKWAY, SUITE 500, LAS VEGAS
- Signature
- /s/ Joshua N. Silverman
- Signature date
- 07 Jan 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PMCB
transaction
Common Stock
Purchase
- Transaction value
- $23,493
- Shares
- +30,000
- Change %
- +9.5%
- Price
- $0.7831
- Shares after
- 346,250
- Date
- 05 Jan 2026
- Ownership
- Direct
PMCB
transaction
Common Stock
Purchase
- Transaction value
- $23,667
- Shares
- +30,000
- Change %
- +8.7%
- Price
- $0.7889
- Shares after
- 376,250
- Date
- 06 Jan 2026
- Ownership
- Direct
PMCB
transaction
Common Stock
Purchase
- Transaction value
- $33,316
- Shares
- +40,000
- Change %
- +11%
- Price
- $0.8329
- Shares after
- 416,250
- Date
- 07 Jan 2026
- Ownership
- Direct
PMCB
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 50,000
- Date
- 05 Jan 2026
- Ownership
- JNS Holdings Group LLC
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
Exhibit 24.1, Power of Attorney